Search hospitals
>
Kansas
>
Overland Park
Saint Luke's South Hospital
Claim this profile
Overland Park, Kansas 66213
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Ovarian Cancer
Conducts research for Breast cancer
Conducts research for Leukemia
170 reported clinical trials
7 medical researchers
Summary
Saint Luke's South Hospital is a medical facility located in Overland Park, Kansas. This center is recognized for care of Lung Cancer, Breast Cancer, Ovarian Cancer, Breast cancer, Leukemia and other specialties. Saint Luke's South Hospital is involved with conducting 170 clinical trials across 275 conditions. There are 7 research doctors associated with this hospital, such as Janakiraman Subramanian, Rakesh Gaur, Addison R. Tolentino, and Sanjaya Gupta, MD.
Area of expertise
Lung Cancer
Saint Luke's South Hospital has run 32 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Saint Luke's South Hospital has run 29 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Janakiraman Subramanian
Saint Luke's Hospital of Kansas City
6 years of reported clinical research
Rakesh Gaur
Research Medical Center
10 years of reported clinical research
Addison R. Tolentino
Saint Luke's Hospital of Kansas City
11 years of reported clinical research
Sanjaya Gupta, MD
Saint Luke's Hospital of Kansas City
2 years of reported clinical research
Clinical Trials running at Saint Luke's South Hospital
Lung Cancer
Non-Small Cell Lung Cancer
Brain Tumor
Cardiotoxicity
Breast cancer
Multiple Myeloma
Colon Cancer
Meningioma
Squamous Cell Carcinoma
Breast Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint Luke's South Hospital?
Saint Luke's South Hospital is a medical facility located in Overland Park, Kansas. This center is recognized for care of Lung Cancer, Breast Cancer, Ovarian Cancer, Breast cancer, Leukemia and other specialties. Saint Luke's South Hospital is involved with conducting 170 clinical trials across 275 conditions. There are 7 research doctors associated with this hospital, such as Janakiraman Subramanian, Rakesh Gaur, Addison R. Tolentino, and Sanjaya Gupta, MD.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.